Amneal Pharma to invest Rs 1,600 crore in Gujarat to make GLP-1 drugs

Quick Summary:

The company has invested $600 million in India over the past 10 years.

Chawla noted that work has already begun, and soon GLP-1RA drugs will be made in India under the production-linked incentive (PLI) scheme.

In July, Arunish Chawla, secretary, Department of Pharmaceuticals (DoP), said the local pharmaceutical industry is already working on producing these drugs domestically once patents expire around 2026.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaIreland

Topics: Gujarat Indian companies Amneal Pharmaceuticals PLI scheme

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-08 @ 17:15:51 (11 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 368 words

Reading Time: 3 minutes read

Sentences: 15 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22953413

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 342 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions